If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
547.50    0.00 (0.00%)
Bid:
0.00
Ask:
595.00
Spread: 49.00 (8.974%)
Market Cap: £1.48b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Contract Award

19 Apr 2018 07:00

RNS Number : 3744L
Chemring Group PLC
19 April 2018
 

FOR IMMEDIATE RELEASE 19 APRIL 2018

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

 

CONTRACT AWARDS

 

Chemring Group is pleased to announce that the UK Ministry of Defence ("MOD") has now confirmed orders for the next two years totalling approximately £23 million.

 

All contracts are with UK based subsidiaries and are for the supply of countermeasures (£11 million), pyrotechnic products (£8 million) and a range of demolition stores (£4 million).

 

Deliveries under these contracts will be made during the MOD's financial years commencing April 2018 and April 2019.

 

Michael Flowers, Group Chief Executive of Chemring, commented:

 

"We are delighted to receive these awards in support of the UK MOD which further underpin our plans for FY18 and help to build order coverage for FY19.

 

"As the UK MOD seeks to provide the armed forces with the highest level of protection, receipt of these contracts is testament to both the trusted position that Chemring holds with its key domestic customer and the mission-critical nature of our products in protecting the lives of our armed forces.

 

"We look forward to continuing to deliver the highest performing and highest quality products in support of our customers."

 

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

James White

 

 

 

 

 

Notes to editors

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

No statement in this announcement is intended as a profit forecast for FY17 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKFDKPBKDAQD
Date   Source Headline
27th Jan 201512:08 pmRNSDirector/PDMR Shareholding
27th Jan 201512:03 pmRNSDirector/PDMR Shareholding
23rd Jan 20154:33 pmRNSDirector Declaration
22nd Jan 20157:00 amRNSFULL YEAR RESULTS
2nd Jan 201512:59 pmRNSTotal Voting Rights
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201410:26 amRNSBlocklisting Interim Review
1st Dec 20141:26 pmRNSHolding(s) in Company
1st Dec 20141:22 pmRNSTotal Voting Rights
25th Nov 20147:00 amRNSPOST-CLOSE STATEMENT
3rd Nov 20142:36 pmRNSTotal Voting Rights
1st Oct 201410:04 amRNSTotal Voting Rights
17th Sep 20147:00 amRNSInterim Management Statement
1st Sep 20142:52 pmRNSTotal Voting Rights
8th Aug 201412:28 pmRNSDirector/PDMR Shareholding
1st Aug 201410:34 amRNSTotal Voting Rights
21st Jul 201410:03 amRNSDirector/PDMR Shareholding
9th Jul 201411:57 amRNSDirector/PDMR Shareholding
2nd Jul 20147:30 amRNSHolding(s) in Company
1st Jul 201412:10 pmRNSDirector/PDMR Shareholding
1st Jul 20149:38 amRNSHolding(s) in Company
1st Jul 20149:00 amRNSChange of Registered Office
24th Jun 20147:00 amRNSDirectorate Change
24th Jun 20147:00 amRNSHalf Yearly Report
18th Jun 201411:00 amRNSBlocklisting Interim Review
30th May 20144:59 pmRNSTotal Voting Rights
27th May 20143:29 pmRNSHolding(s) in Company
27th May 20142:37 pmRNSCompletion of Disposal of European Munitions
22nd May 20147:00 amRNSUpdate on Disposal
12th May 20149:40 amRNSResult of EGM
9th May 20147:00 amRNSACQUISITION OF 3D-RADAR
1st May 201412:18 pmRNSTotal Voting Rights
30th Apr 201411:34 amRNSDirector/PDMR Shareholding
29th Apr 20141:20 pmRNSDirector/PDMR Shareholding
29th Apr 201412:42 pmRNSPDMR Shareholding
29th Apr 201411:59 amRNSDirector/PDMR Shareholding
29th Apr 201411:58 amRNSDirector/PDMR Shareholding
29th Apr 201411:57 amRNSDirector/PDMR Shareholding
29th Apr 201411:14 amRNSHolding(s) in Company
24th Apr 20144:30 pmRNSPublication of Circular
24th Apr 20147:00 amRNSDisposal
15th Apr 201412:11 pmRNSDirector Declaration
14th Apr 201411:15 amRNSBlocklisting update
9th Apr 201410:12 amRNSAdditional Listing
26th Mar 20144:16 pmRNSDoc re. Ordinary & Special Resolutions
20th Mar 20142:04 pmRNSResult of AGM
3rd Mar 201410:11 amRNSTotal Voting Rights
27th Feb 20147:00 amRNSInterim Management Statement
6th Feb 201412:18 pmRNSHolding(s) in Company
3rd Feb 201410:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.